J & J pays $158 million to settle Texas Medicaid fraud lawsuit

Share this article:
J & J pays $158 million to settle Texas Medicaid fraud lawsuit
J & J pays $158 million to settle Texas Medicaid fraud lawsuit

Johnson & Johnson has agreed to pay $158 million to settle a Medicaid fraud lawsuit.

The lawsuit accused J & J subsidiary Janssen Pharmaceuticals of giving state officials kickbacks in exchange for putting the antipsychotic Risperdal on an approved list for Medicaid recipients. The suit also claimed that Janssen marketed the drug as being a safe and cost-effective, despite the fact that it was linked to an increased risk of stroke and death in elderly dementia patients. Risperdal is only approved to treat adult schizophrenia.

Lawyers representing the state of Texas originally asked that Janssen repay $579 million to the state's Medicaid program, plus up to $500 million in penalties, the Associated Press reported.

"Janssen ran amok,” Allen Jones, one of the plaintiffs, told the AP. “They trashed the Johnson & Johnson credo, and they misused Texas and, I believe, well-meaning officials to further their marketing.”

Johnson & Johnson was recently ordered to pay $327 million in South Carolina and the $258 million in Louisiana in similar Risperdal lawsuits.

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.